138 related articles for article (PubMed ID: 36314449)
41. Virilization in a Girl Caused by an Ovarian Yolk Sac Tumor: A Case Report.
Yang M; Xin Y
J Pediatr Adolesc Gynecol; 2019 Jun; 32(3):330-333. PubMed ID: 30630034
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
43. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
[TBL] [Abstract][Full Text] [Related]
44. Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma.
Tian Q; Lu B; Ye J; Lu W; Xie X; Wang X
J Int Med Res; 2016 Apr; 44(2):357-66. PubMed ID: 26880793
[TBL] [Abstract][Full Text] [Related]
45. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
46. Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Kommoss F; Schmidt M; Merz E; Knapstein PG; Young RH; Scully RE
Gynecol Oncol; 1999 Mar; 72(3):421-4. PubMed ID: 10053117
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study.
Geng R; Zheng Z; Lin Y; Li Y; Ge G; Zhang J; Wang C; Dai X; Ye Q; Zhen J; Zhang Y; Fu C; Li Y
World J Urol; 2021 Apr; 39(4):1211-1217. PubMed ID: 32562046
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory role of prohibitin in human ovarian epithelial cancer.
Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
[TBL] [Abstract][Full Text] [Related]
49. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
[TBL] [Abstract][Full Text] [Related]
50. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients.
Mizuno M; Kajiyama H; Shibata K; Mizuno K; Kawai M; Nagasaka T; Kikkawa F
Br J Cancer; 2015 Apr; 112(8):1376-83. PubMed ID: 25867257
[TBL] [Abstract][Full Text] [Related]
52. Primary juxtaovarian yolk sac tumor concurrent with an ipsilateral ovarian mature teratoma in an adult woman: a rare association.
Ma H; Yu J; Tang J; Wang M
Int J Clin Exp Pathol; 2015; 8(1):1046-9. PubMed ID: 25755817
[TBL] [Abstract][Full Text] [Related]
53. [Pathological diagnosis of ovarian cancer].
Yamabe H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
[No Abstract] [Full Text] [Related]
54. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
[TBL] [Abstract][Full Text] [Related]
55. Mucinous Proliferations of the Uterine Corpus: Comprehensive Appraisal of an Evolving Spectrum of Neoplasms.
Fadare O
Adv Anat Pathol; 2022 Sep; 29(5):275-296. PubMed ID: 35499137
[TBL] [Abstract][Full Text] [Related]
56. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
57. Yolk sac tumor of the ovary: a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit (TGCU).
Kojimahara T; Nakahara K; Takano T; Yaegashi N; Nishiyama H; Fujimori K; Sato N; Terada Y; Tase T; Yokoyama Y; Mizunuma H; Shoji T; Sugiyama T; Kurachi H
Tohoku J Exp Med; 2013 Aug; 230(4):211-7. PubMed ID: 23912096
[TBL] [Abstract][Full Text] [Related]
58. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
[TBL] [Abstract][Full Text] [Related]
59. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
60. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
